HLA-DQ2 is a genetic risk factor for celiac disease, an autoimmune condition triggered by gluten. About 25–30% of Europeans carry HLA-DQ2, but only a minority develop celiac. Its role in gut health is indirect: in susceptible individuals, gluten exposure can activate an immune response that damages intestinal villi, leading to malabsorption, inflammation, and diarrhea. However, a positive HLA-DQ2 test alone does not diagnose celiac disease—clinical confirmation requires antibody tests and duodenal biopsy. For general gut health, the variant is not a direct marker; many carriers have no symptoms. MyBody-X can detect HLA-DQ2, but results should be interpreted by a physician. Without symptoms or positive serology, the finding has limited actionable value. Evidence: strong for celiac association, but for overall gut health the effect is moderate because penetrance is low.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-4c2f278fd9f2c9e738c22550